Drug-labels.com

Mar-Glycopyrrolate: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
1 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Mar-Glycopyrrolate

What is MAR-GLYCOPYRROLATE used for?

MAR-GLYCOPYRROLATE is used for reducing drooling caused by certain health problems. It is for patients that are 3-18 years old.

How does MAR-GLYCOPYRROLATE work?

MAR-GLYCOPYRROLATE reduces the rate of drooling. This is done by blocking receptors on the glands that make saliva.

What are the ingredients in MAR-GLYCOPYRROLATE?

Medicinal ingredients: Glycopyrrolate

Non-medicinal ingredients: Citric acid monohydrate, cherry flavor, glycerol, liquid sorbitol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, propylene glycol, purified water, saccharin sodium, sodium citrate.

Composition of Cherry Flavour: Natural Anisyl Acetate, Natural Benzaldehyde, Natural Benzyl Acetate, Natural Benzyl Alcohol, Natural Cinnamaldehyde, Natural Ethyl Acetate, Natural Ethyl Butyrate, Natural gamma-Undecalactone, Natural Geraniol, Natural Isoamyl Butyrate, Natural Isobutyl Acetate, Natural Maltol, Natural p-Anisaldehyde, Natural Raspberry Ketone, Tolu Balsam, Propylene Glycol

MAR-GLYCOPYRROLATE comes in the following dosage form:

Oral solution, 1 mg/5 mL.

Do not use MAR-GLYCOPYRROLATE if your child:

  • is allergic to glycopyrrolate or any of the other ingredients.
  • has an eye problem where the pressure inside the eye is too high (glaucoma).
  • has a blockage or backward flow of urine drainage from the kidney, ureter, or bladder.
  • has a blockage that keeps food or liquid from passing through the small or large intestine.
  • has a blockage in the intestine due to either paralysis or weakening of the intestinal muscles.
  • has unstable cardiovascular status.
  • has severe ulcerative colitis with or without other serious bowel problems.
  • has a disease that makes the voluntary muscles more weak and tired.
  • is taking a solid oral form (e.g. a tablet) of potassium chloride.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you give your child MAR-GLYCOPYRROLATE. Talk about any health conditions or problems you may have, including if your child:

  • has any stomach or bowel problems, including ulcerative colitis.
  • has any problems with constipation.
  • has any problems with diarrhea.
  • has thyroid problems.
  • has high blood pressure.
  • has heart problems or abnormal heart beats.
  • has a hiatal hernia with gastroesophageal reflux disease (GERD).
  • has any problems urinating.
  • has any other medical conditions.
  • is pregnant or plans to become pregnant. It is not known if MAR-GLYCOPYRROLATE can harm an unborn baby.

  • is breastfeeding or plans to breastfeed. It is not known if MAR-GLYCOPYRROLATE passes into breast milk and if it can harm the baby.
  • has kidney problems.
  • has poorly controlled mental conditions and/or seizures.

Other warnings you should know about:

MAR-GLYCOPYRROLATE can cause your child to sweat less. Your child can become overheated. If your child is in an area that is very hot, they may develop heat stroke.

MAR-GLYCOPYRROLATE may cause sleepiness or blurred vision. Your child should not drive a car or operate heavy machinery. Your child should not do other risky activities while taking MAR-GLYCOPYRROLATE.

Tell your healthcare professional about all the medicines your child takes, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with MAR-GLYCOPYRROLATE:

  • anticholinergic agents (diphenhydramine, phenothiazines, tricyclic antidepressants)
  • amatandine
  • atenolol
  • cannabinoids (dronabinol, nabilone)
  • digoxin
  • haloperidol
  • levodopa
  • metformin
  • monoamine oxidase inhibitors (e.g. moclobemide, phenelzine, procarbazine, rasagiline,

    • selegiline, tranylcypromine)
  • solid oral dosage forms of potassium chloride

Ask your healthcare provider or pharmacist if you are not sure if a medicine your child takes is one that is listed above.

How to give MAR-GLYCOPYRROLATE:

  • Give 1 hour before or 2 hours after meals.

  • Give exactly as prescribed by your child’s doctor. Do not change the dose of MAR-GLYCOPYRROLATE unless your doctor tells you to.
  • Pour the approximate dose into a specially marked dose measuring cup, then use an oral syringe to accurately measure the correct amount of MAR-GLYCOPYRROLATE. Dosing cups and oral syringes are available at most pharmacies. DO NOT insert the oral syringes into the bottle.
  • For questions on how to measure the dose or use an oral syringe, ask your pharmacist or doctor.
  • Administer the dose using the oral syringe. Make sure that your child swallows the dose.
  • Thoroughly wash the syringe and dose cup with warm water after each use.
  • Any unused solution remaining in the dose cup should be discarded after each use.
  • The syringe and dose cup should be clean and dry prior to each use.
  • Discard 30 days after opening the bottle.

Usual dose:

Your doctor will tell you how much MAR-GLYCOPYRROLATE (millilitres or mLs) to give your child. The usual starting dose is 0.02 mg/kg orally three times daily. Your doctor will adjust the dose over time based on your child’s response and side effects. The maximum recommended dose is 0.1 mg/kg three times daily and should not be greater than 1.5 – 3 mg (7.5 mL – 15 mL) per dose based upon weight.

Overdose:

MAR-GLYCOPYRROLATE contains benzyl alcohol (0.1 mg/5 ml). Overdosage may result in serious adverse effects.

Missed Dose:

If you miss giving a dose of MAR-GLYCOPYRROLATE to your child and it is:

  • within 2 hours of the usual dose time, give your child the missed dose immediately, unless a meal has been eaten within the last 2 hours. Do not feed your child a meal for 1 hour after giving them MAR-GLYCOPYRROLATE.
  • more than 2 hours since the usual dose time, do not give your child the missed dose. Give the next

If you think you , or a person you are caring for, have taken too much MAR-GLYCOPYRROLATE , contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

  • dose at the regular dose time.

Do not give your child a double dose to make up for a forgotten dose.

What are possible side effects from using MAR-GLYCOPYRROLATE?

These are not all the possible side effects you may feel when taking MAR-GLYCOPYRROLATE. If you experience any side effects not listed here, contact your healthcare professional. Please also see Other warnings you should know about.

The most common side effects of MAR-GLYCOPYRROLATE include:

  • dry mouth.
  • vomiting.
  • constipation.
  • flushing of the face or skin.
  • headache.
  • problem urinating, difficulty starting urination.
  • rapid heart beat.

Serious side effects and what to do about them

Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases

VERY COMMON

Constipation:

  • Straining with bowel movements.
  • Longer time between bowel movements.
  • Cannot have a bowel movement.
  • Stomach is firm and large.
X

COMMON

Diarrhea:

  • This can be an early symptom of intestinal blockage. This is more likely if your child has had a

    colostomy or ileostomy.

X

UNKNOWN

Problems with control of body temperature:

  • Hot and red skin.
  • Less alert or passing out.
  • Fast and weak pulse.
  • Fast and shallow breathing.
  • Fever.
X

If your child has a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your child’s daily activities, talk to your healthcare professional.

Storage:

Store at 15°C - 25°C. Do not refrigerate or freeze. Discard 30 days after first opening.

Keep MAR-GLYCOPYRROLATE out of reach and sight of children.

If you want more information about MAR-GLYCOPYRROLATE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.marcanpharma.com or by calling 1-855-627-2261.

Last revised: OCT 23, 2026

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02572974

Revision date stated in the text: October 23, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mar-Glycopyrrolate

Rx or OTC
Prescription (Rx)?
DIN 02572974
Schedule(s) PRESCRIPTION
Active ingredient(s) Glycopyrrolate 1 MG
Dosage form(s) Solution
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03A Drugs for functional gastrointestinal disorders
        1. A03AB Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders
          1. A03AB02 Glycopyrronium
Company MARCAN PHARMACEUTICALS INC
Current status Approved
Current status date October 23, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.